- 会見
- 原告
- 効果
- 女性
- 東京地裁
- 見解
- 中央
- 大阪市
- 奈良県
- 姿勢
「がんワクチン」の写真・グラフィックス・映像
- 提供元
- 日付
- 種類
- 向き
- カテゴリ
- 色
- 同義語オン
- 提供元
- 日付
- 24時間以内 0
- 48時間以内 0
- 72時間以内 0
- 7日以内 0
- 30日以内 0
- 1年以内 0
- 期間を指定 242
- 日付指定なし 242
- 種類
- 写真 198
- グラフィックス 42
- 映像 2
- 向き
- 縦 39
- 横 161
- 正方形 10
- カテゴリ
- ニュース
- スポーツ
- エンターテインメント
- 教育向け
- カテゴリ指定なし
- 色
- カラー 221
- モノクロ 21
- 同義語辞書
- 新しい順
- 1
- 2
- 3
- 新しい順
01:31.982023年10月15日Nobel laureate Kariko underscores groundbreaking potential of mRNA technologySTORY: Nobel laureate Kariko underscores groundbreaking potential of mRNA technologyDATELINE: Oct. 15, 2023LENGTH: 00:01:32LOCATION: SZEGED, HungaryCATEGORY: SCIENCESHOTLIST:1. various of the panel discussionSTORYLINE:Biochemist Katalin Kariko, 2023 Nobel laureate in physiology or medicine, underscored the application potential of mRNA technology in a panel discussion at her alma mater, University of Szeged, on Thursday evening.Originally focused on cancer vaccines, mRNA‘s versatility has broadened to encompass various therapeutic applications, particularly in the rapidly evolving field of therapy drugs, she explained to an audience made up mostly of university students in response to a question from Xinhua.“Definitely, the messenger RNA (mRNA) as a therapy will be used for many, many applications, many different treatments, and therapies,“ she said...＝ 配信日： ２０２３（令和５）年１０月１５日、クレジット：新華社／共同通信イメージズ
商品コード: 2023101510314
2023年03月31日９価ワクチンの留意点子宮頸がんワクチンの接種を受ける女性
商品コード: 2023033105346
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308370
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050303634
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308379
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304271
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308371
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304396
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308591
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304233
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308317
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304709
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050300784
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308352
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050303631
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308363
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308367
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304313
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308332
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304221
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050300467
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308310
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050300549
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308257
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304725
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308395
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050300688
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308513
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308361
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050303645
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308477
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304247
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304378
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308281
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308425
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304234
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304707
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308298
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304259
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308421
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308036
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304249
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050303650
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308479
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304253
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308283
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308300
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050300722
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308543
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050303643
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304208
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308293
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308498
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304248
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304374
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308302
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308339
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304349
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304283
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308347
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304733
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308453
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308295
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304332
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308496
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304729
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304407
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308386
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050303641
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308377
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304256
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308522
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308362
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. Employees at the company get these commemorative vials for any vaccines that go to clinical trials while they work at the company. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304264
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050303596
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308411
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304423
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308358
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308408
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050300678
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050303622
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308314
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308307
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304204
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050303608
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308457
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308447
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304276
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308334
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304228
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050300675
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308354
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308041
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304694
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304717
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308315
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304211
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308490
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050308289
2022年11月14日Moderna offices in Cambridge, Massachusetts,Nov 14, 2022 - Cambridge, Massachusetts, United States - Seen in his office during an interview with Le Point reporter Francois Miguet, STEPHANE BANCEL is the CEO of the pharmaceutical and biotechnology company Moderna, seen here at Moderna‘s offices in Cambridge, Massachusetts, USA, on Mon., Nov. 14, 2022. Moderna is best-known for its mRNA COVID-19 vaccine, but is working on vaccines for other diseases including a personal cancer vaccine. (Credit Image: © M. Scott Brauer/ZUMA Press Wire)、クレジット：©Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｍａｙ ｎｏｔ ｂｅ ｕｓｅｄ ｗｉｔｈｏｕｔ ｐｅｒｍｉｓｓｉｏｎ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ ｏｒ ａｎ ａｐｐｒｏｖｅｄ ａｇｅｎｔ ｏｆ Ｍ． Ｓｃｏｔｔ Ｂｒａｕｅｒ． Ｂｕｙｅｒ ａｇｒｅｅｓ ｔｏ ｐｒｏｖｉｄｅ ｐｄｆ ｔｅａｒｓｈｅｅｔ ｏｆ ｕｓａｇｅ ｗｈｅｒｅ ａｐｐｒｏｐｒｉａｔｅ．
商品コード: 2023050304186
- 1
- 2
- 3
